CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY (UNAUDITED) - USD ($) $ in Thousands	Total	Total Rithm Capital Stockholders’ Equity	Preferred Stock	Common Stock	Additional Paid-in Capital	Retained Earnings (Accumulated Deficit)	Accumulated Other Comprehensive Income	Noncontrolling Interests in Equity of Consolidated Subsidiaries
Preferred stock, beginning balance (in shares) at Dec. 31, 2022			51,964,122,000
Beginning balance at Dec. 31, 2022	$ 7,010,068	$ 6,943,001	$ 1,257,254	$ 4,739	$ 6,062,019	$ (418,662)	$ 37,651	$ 67,067
Common stock, beginning balance (in shares) at Dec. 31, 2022				473,715,100,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Dividends declared on common stock	(120,754)	(120,754)				(120,754)
Dividends declared on preferred stock	(22,395)	(22,395)				(22,395)
Capital distributions	(5,430)							(5,430)
Cashless exercise of 2020 Warrants (in shares)				9,287,347,000
Cashless exercise of 2020 Warrants	0			$ 93	(93)
Director share grants and employee non-cash stock-based compensation (in shares)				15,300,000
Director share grants and employee non-cash stock-based compensation	125	125			125
Comprehensive income (loss)
Net income (loss)	89,949	91,249				91,249		(1,300)
Unrealized gain (loss) on available-for-sale securities, net	2,980	2,980					2,980
Cumulative translation adjustment	0
Deferred taxes	0
Comprehensive income (loss)	92,929	94,229						(1,300)
Preferred stock, ending balance (in shares) at Mar. 31, 2023			51,964,122,000
Ending balance at Mar. 31, 2023	6,954,543	6,894,206	$ 1,257,254	$ 4,832	6,062,051	(470,562)	40,631	60,337
Common stock, ending balance (in shares) at Mar. 31, 2023				483,017,747,000
Preferred stock, beginning balance (in shares) at Dec. 31, 2022			51,964,122,000
Beginning balance at Dec. 31, 2022	$ 7,010,068	6,943,001	$ 1,257,254	$ 4,739	6,062,019	(418,662)	37,651	67,067
Common stock, beginning balance (in shares) at Dec. 31, 2022				473,715,100,000
Preferred stock, ending balance (in shares) at Dec. 31, 2023	51,964,122		51,964,122,000
Ending balance at Dec. 31, 2023	$ 7,101,038	7,006,942	$ 1,257,254	$ 4,833	6,074,322	(373,141)	43,674	94,096
Common stock, ending balance (in shares) at Dec. 31, 2023	483,226,239			483,226,239,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Dividends declared on common stock	$ (120,869)	(120,869)				(120,869)
Dividends declared on preferred stock	(22,395)	(22,395)				(22,395)
Capital contributions	2,138							2,138
Capital distributions			$ (5,866)					(5,866)
Director share grants and employee non-cash stock-based compensation (in shares)				251,474,000
Director share grants and employee non-cash stock-based compensation	1,012	1,012		$ 3	758	251
Comprehensive income (loss)
Net income (loss)	287,487	284,035				284,035		3,452
Unrealized gain (loss) on available-for-sale securities, net	1,603	1,603					1,603
Cumulative translation adjustment	(870)	(870)					(870)
Deferred taxes	94	94					94
Comprehensive income (loss)	$ 288,314	284,862						3,452
Preferred stock, ending balance (in shares) at Mar. 31, 2024	51,964,122		51,964,122,000
Ending balance at Mar. 31, 2024	$ 7,243,372	$ 7,149,552	$ 1,257,254	$ 4,836	$ 6,075,080	$ (232,119)	$ 44,501	$ 93,820
Common stock, ending balance (in shares) at Mar. 31, 2024	483,477,713			483,477,713,000